Kisqali 400 MG daily dose 42S
Ended Awarded
- Contract number
- SPE2DB25FQ2N4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,625
Award facts
- Contract value 100% obligated
- $14,624.66 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $14,624.66 on September 11, 2025, for the supply of Kisqali 400 mg daily dose medication in a 42-count package. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 12, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal medical procurement vendor for military and veteran healthcare systems. The company's extensive portfolio of federal contracts demonstrates its capability to fulfill a wide range of pharmaceutical supply needs across multiple therapeutic domains through open competition. Kisqali, a hormone therapy medication used in oncology treatment, represents one of the specialized pharmaceutical products the company routinely supplies to the Defense Health Agency and other federal healthcare systems through its prime IDC with DLA Troop Support.
Quick answers
Who was awarded contract SPE2DB25FQ2N4?
SPE2DB25FQ2N4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 11, 2025.
How much is contract SPE2DB25FQ2N4 worth?
The government has obligated $14,625 on SPE2DB25FQ2N4.
Is contract SPE2DB25FQ2N4 an order under another contract?
Yes. SPE2DB25FQ2N4 is a delivery order under SPE2DB20D3103, an indefinite delivery contract.
Was contract SPE2DB25FQ2N4 competed?
The extent of competition for SPE2DB25FQ2N4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award